D
Désirée Deandreis
Researcher at University of Turin
Publications - 53
Citations - 950
Désirée Deandreis is an academic researcher from University of Turin. The author has contributed to research in topics: Thyroid & Thyroid cancer. The author has an hindex of 11, co-authored 53 publications receiving 620 citations. Previous affiliations of Désirée Deandreis include Université Paris-Saclay & Institut Gustave Roussy.
Papers
More filters
Journal ArticleDOI
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?
Sophie Leboulleux,Désirée Deandreis,A. Al Ghuzlan,Anne Auperin,Diane Goéré,Clarisse Dromain,Dominique Elias,Bernard Caillou,Jean-Paul Travagli,T. de Baere,Jean Lumbroso,Jacques Young,M. Schlumberger,Eric Baudin +13 more
TL;DR: An increased risk of PC after laparoscopic adrenalectomy (LA) for ACC is found, whether this is related to an inappropriate surgical approach or to insufficient experience in ACC surgery should be clarified by a prospective program.
Journal ArticleDOI
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
Ettore Pelosi,Patrizia Pregno,Daniele Penna,Désirée Deandreis,Annalisa Chiappella,G. Limerutti,Umberto Vitolo,M. Mancini,Giovanni Bisi,Eugenio Gallo +9 more
TL;DR: The data confirm the high accuracy of FDG-PET/CT in staging HL and NHL and should therefore be used routinely in the initial evaluation of both patient subgroups.
Journal Article
Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
TL;DR: The data strongly support the diagnostic contribution of whole body FDG-PET/CT scan in the evaluation of patients with CUP syndrome and suggest its use in an early phase of the diagnostic iter to optimize patient management.
Journal ArticleDOI
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
Giulia Polverari,Francesco Ceci,Valentina Bertaglia,Maria Lucia Reale,Osvaldo Rampado,E. Gallio,Roberto Passera,Virginia Liberini,Paola Scapoli,Vincenzo Arena,Manuela Racca,Andrea Veltri,Silvia Novello,Désirée Deandreis +13 more
TL;DR: 18F-FDG PET/CT performed before the start of immunotherapy might be an important prognostic tool able to predict the disease progression and response to immunotherapy in patients with advanced NSCLC, since MTV, TLG and radiomics features (volume and heterogeneity) are associated with disease progression.
Journal Article
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Ettore Pelosi,Daniele Penna,Désirée Deandreis,Annalisa Chiappella,Andrea Skanjeti,Umberto Vitolo,Giovanni Bisi +6 more
TL;DR: This study demonstrates that BMb and FDG-PET are complementary in the evaluation of BMD, and improves the sensitivity of BMb, especially in the presence of focal BMD.